Overview

Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy

Status:
Unknown status

Trial end date:
2020-07-28

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate the efficacy and safety of simiaowan in prevention of acute flares in chronic gout patients initiating febuxostat therapy.

Phase:

N/A

Details

Lead Sponsor:

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Collaborators:

Shenzhen Traditional Chinese Medicine Hospital
The Second Affiliated Hospital of Dalian Medical University

Treatments:

Febuxostat